Biotech Values

[DewDiligence]

Kathleen Uhl is new acting director of OGD* while FDA searches for permanent hire:

http://in.reuters.com/article/2013/03/19/us-fda-generics-director-idINBRE92I0S120130319

Janet Woodcock (head of CDER) had been the acting OGD director since Gregory Geba resigned last week.

*Office of Generic Drugs.